论文部分内容阅读
Aim: The study is to investigate whether diuretic acetazolamide (AZA) protects against renal ischemia-reperfusion (I/R) injury, and its possible link with water channel aquaporin-1 (AQP1).Methods: In vivo study was conducted using AQP1 wild-type (AQP1+/+) and knock-out (AQP1-/-) mice, randomly divided into three groups: sham, I/R and AZA treatment group.